Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RXII

RXi Pharmaceuticals

$2.50

0.16 (6.84%)

12:00
05/18/18
05/18
12:00
05/18/18
12:00
Hot Stocks
RXi Pharma says Phase 2 Samcyprone trial met primary effectiveness objectives »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$2.37

0.03 (1.28%)

11:23
05/18/18
05/18
11:23
05/18/18
11:23
Hot Stocks
RXi Pharmaceuticals rises after posting presentation day poster to site »

Shares of RXi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$2.24

0.225 (11.19%)

, IOVA

Iovance Biotherapeutics

$14.80

-0.3 (-1.99%)

07:10
05/11/18
05/11
07:10
05/11/18
07:10
Hot Stocks
RXi Pharmaceuticals and Iovance Biotherapeutics partner in cancer treatment »

RXi Pharmaceuticals…

RXII

RXi Pharmaceuticals

$2.24

0.225 (11.19%)

IOVA

Iovance Biotherapeutics

$14.80

-0.3 (-1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

RXII

RXi Pharmaceuticals

$2.01

-0.28 (-12.23%)

17:34
05/09/18
05/09
17:34
05/09/18
17:34
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

RXII

RXi Pharmaceuticals

$2.29

-0.13 (-5.37%)

14:24
05/08/18
05/08
14:24
05/08/18
14:24
Hot Stocks
RXi Pharmaceuticals granted patent from USPTO for sd-rxRNA methods of use »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

RXII

RXi Pharmaceuticals

$2.42

(0.00%)

09:40
05/08/18
05/08
09:40
05/08/18
09:40
Hot Stocks
RXi Pharmaceuticals assigned patent for methods of use of RNAi compounds 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

Over a month ago
RXII

RXi Pharmaceuticals

$2.75

(0.00%)

17:24
04/18/18
04/18
17:24
04/18/18
17:24
Hot Stocks
Breaking Hot Stocks news story on RXi Pharmaceuticals »

Anson Funds Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$2.75

(0.00%)

16:57
04/18/18
04/18
16:57
04/18/18
16:57
Hot Stocks
Breaking Hot Stocks news story on RXi Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$2.92

-0.03 (-1.02%)

07:07
04/13/18
04/13
07:07
04/13/18
07:07
Hot Stocks
Lincoln Park reports 9.99% passive stake in RXi Pharmaceuticals »

Lincoln Park Capital Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXII

RXi Pharmaceuticals

$3.02

0.03 (1.00%)

12:58
04/11/18
04/11
12:58
04/11/18
12:58
Syndicate
RXi Pharmaceuticals sells 1.51M shares at $3.15 in registered direct offering »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.